Immune protection application of staphylococcus aureus EsxB protein
A staphylococcus, immune protection technology, applied in the field of immune vaccines, can solve the problem of weakening pathogenicity and achieve remarkable results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0012] 1. Preparation of EsxB vaccine
[0013] The EsxB vaccine was prepared respectively with the mass ratio of EsxB protein / aluminum hydroxide adjuvant as 1:2.5.
[0014] 2. Immunization of BALB / c mice
[0015] Immunized mice:
[0016] EsxB vaccine group: on days 1, 7, and 21, 200 μL of vaccine containing 200 μg / mL EsxB and 500 μg / mL aluminum hydroxide adjuvant was subcutaneously injected into the back of each four-week-old mouse, and blood was collected intravenously on day 28 to detect anti- EsxB Antibody Production.
[0017] Control group: On days 1, 7, and 21, each mouse was subcutaneously injected with 200 μL of vaccine containing 500 μg / mL aluminum hydroxide adjuvant on the back, and blood was collected intravenously on day 28.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 